Find Clinical Trials
Evaluation of the effects of 3 successive oral dosages (2.5, 5, 7.5 mg b.i.d.) of ivabradine in patients with stable moderate to severe systolic chronic heart failure treated with beta-blockers. A 9 week pilot, open labelled, international multicenter study
Servier Protocol Code:
CL2-16257-062
Sponsor:
Institut de Recherches Internationales Servier (I.R.I.S)
EudraCT Number:
2005-000103-34
Find a recruiting site
Name:
Institut de Recherches Internationales Servier, Département des études cliniques
Phone number:
+33 1 55 72 60 00
Results
English (USA)Interventions / Treatments
The treatment(s) given to the participants in the study.
- Heart failure
- IVABRADINE
- S016257
Other study id numbers
Other identification numbers the study may be known by.
- CL2-16257-062